← All stocks

IMMUNIC, INC.

IMUX Net buying
CIK 0001280776 #3859 in the set updated 22 Sep 2026
Bought (120 mo)
$18.50M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$4.50M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$4.50M
16 of 16 sales
Net
+$14.00M
+$14.00M against sales at will

By person

18 insiders · 68 transactions
1.0×

Dr. Daniel Vitt holds only 1.0 times base salary in stock. $654.20K of shares against $625.25K in salary for 2025.

Salary from the company's own proxy. The shares are what Dr. Daniel Vitt last reported holding, valued at $0.83, the price Common Stock was last bought or sold at on the open market here, on 13 Jun 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Satter Muneer A
Director
$17.20M (17)
$4.15M (3)
+$13.05M
0
$0.00
−100.0%
Neermann Joerg
Director
$204.36K (5)
+$204.36K
200,000
$166.94K
Rudick Richard Alan
Director
$200.39K (2)
+$200.39K
230,375
$192.29K
Muehler Andreas
Chief Medical Officer
$173.34K (2)
+$173.34K
297,986
$248.73K
+4.7%
Hasnain Faheem
Director
$247.87K (1)
$77.68K (2)
+$170.19K
8,000
$6.68K
−93.7%
Whaley Glenn
Chief Financial Officer
$124.41K (8)
+$124.41K
95,510
$79.72K
+1,633%
Nash Duane
Executive Chairman
$139.98K (5)
$30.62K (1)
+$109.35K
36,032
$30.08K
Groeppel Manfred
Chief Operating Officer
$82.36K (2)
−$82.36K
278,830
$232.74K
−2.0%
BIENAIME JEAN JACQUES
Director
$88.04K (2)
$17.40K (2)
+$70.64K
18,500
$15.44K
−52.7%
Winters Terence E.
Co-Chairman and CEO
$30.98K (1)
+$30.98K
314,930
$262.87K
+3.3%
Halperin Errol R.
Director
$28.84K (2)
−$28.84K
0
$0.00
−100.0%
Vitt Daniel
Director
$65.78K (5)
$92.51K (2)
−$26.73K
783,754
$654.20K
+4.9%
Godshall Douglas Evan
Director
$24.19K (1)
−$24.19K
0
$0.00
−100.0%
Tardio Jason
President and COO
$9.88K (1)
+$9.88K
12,512
$10.44K
DUNN JOHN MICHAEL
General Counsel and Secretary
$7.72K (2)
+$7.72K
11,885
$9.92K
+26.6%
Ashley Robert A.
Chief Scientific Officer, EVP
$6.36K (1)
+$6.36K
2,000
$1.67K
Cohen Cheryl
Director
$1.93K (1)
−$1.93K
0
$0.00
−100.0%
BVF PARTNERS L P/IL entity
Director
42,762
$35.69K
0.0%

No percentages here. This company's share count has moved by a factor of 10.0 over the window, from 13,644,467 to 136,214,825 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 203
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 61,087
Sales filed before the plan box existed 16
History held since 27 Mar 2017